This review examines how webs released by immune cells may contribute to MS and other brain disorders.
Certain immune cells release webs that trap germs. Problems with how these webs form or get cleared may contribute to brain disorders. The review discusses how these immune cells enter the brain. It also examines what may trigger the cells to release webs there. The disorders covered include MS, stroke, brain injury, and Alzheimer's disease.
This review covers MS and several other brain disorders. It does not focus only on people with MS. It may interest people who want to understand how immune activity relates to MS. The authors also discuss approaches designed to stop these webs from forming or help break them down. The abstract does not say whether those approaches help people with MS.
You are reading a review of existing research, not a report of a new patient study. The abstract gives no sample size. It does not show that targeting these webs improves MS.
AI-generated summary — for informational purposes only, not medical advice
1/1/2027
A Korean study found higher levels of one Epstein-Barr virus antibody in people with MS. Learn why t
Read More1/1/2027
Explore a study linking a gene change to immune cells in spinal fluid in MS, what those cells may sa
Read More11/7/2026
A new tool labels spine bones and discs on many scans. Learn how this could help doctors review MS-r
Read More11/7/2026
A study of 360 people with MS links past suicide attempts with depression, smoking, and childhood ha
Read More11/6/2026
A malaria study protected brain blood vessels in mice. Learn why this early finding may interest MS
Read More11/6/2026
A study of children with MS linked higher propionate, a substance made in the gut, with less disease
Read MoreWhether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Molecular neurodegeneration often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.
However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.
By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.